Pharmacotherapy of Bone Loss in Postmenopausal Women: Focus on Denosumab

Clinical Medicine. Therapeutics
doi 10.4137/cmt.s1089
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Effect of Denosumab on Trabecular Bone Score in Postmenopausal Women With Osteoporosis

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2017English

Effects of Denosumab on Bone Density, Mass and Strength in Women With Postmenopausal Osteoporosis

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2015English

Study on Bone Loss of Pre- And Postmenopausal Women in AMHTS

Japanese journal of MHTS
1997English

Oral Weekly Ibandronate Prevents Bone Loss in Postmenopausal Women

Journal of Internal Medicine
Internal Medicine
2003English

Phyto-Oestrogen Excretion and Rate of Bone Loss in Postmenopausal Women

European Journal of Clinical Nutrition
MedicineNutritionDietetics
1998English

Denosumab for the Prevention of Osteoporotic Fractures in Postmenopausal Women

Health Technology Assessment
MedicineHealth Policy
2011English

Emerging Evidence on the Link Between Depressive Symptoms and Bone Loss in Postmenopausal Women

International Journal of Women's Health
GynecologyOncologyMidwiferyMaternityObstetrics
2017English

Association Between Tooth Loss and Bone Mineral Density in Brazilian Postmenopausal Women

Journal of Clinical Medicine Research
2011English

Antiresorptive Agents Increase the Effects of Exercise on Preventing Postmenopausal Bone Loss in Women: A Meta-Analysis

PLoS ONE
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy